Krzysztof Bujko

Prof. Krzysztof Bujko


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2023 in Cancers
Verified
Journal Article
Open access
PDF file
JSJOANNA SOCHA
JOANNA SOCHA
Krzysztof BujkoKrzysztof Bujko
Krzysztof Bujko
Background: We aimed to evaluate whether total neoadjuvant therapy (TNT) results in long-term overall survival (OS) or quality of life (QoL) benefit compared with chemoradiation if all patients are being considered for radical resection, and whether the ATRESS phenomenon (i.e., reduction in post-metastatic survival) impacts OS after TNT. Methods: Systematic review of randomised trials comparing TNT with neoadjuvant (chemo)radiation. Results: Six trials were identified. Follow-ups were too short to resolve whether TNT improves long-term OS. QoL analysis in one trial showed worse long-term neurotoxicity-related QoL (any neurotoxicity: 14% vs. 3%), higher rate of grade III+ acute toxicity (48% vs. 25%), longer duration of neoadjuvant treatment (19 vs. 6 weeks) and higher rate of locoregional failure (10% vs. 7%) in TNT vs. chemoradiation. This should be weighed against an absolute 8% reduction in the incidence of distant metastases (DM) after TNT. ATRESS could explain a discrepancy between reduction of DM and the absence of OS improvement after TNT in one trial. Conclusion: In the light of unproven OS benefit, the gain of TNT (reduction of DM) does not seem to outweigh the harm (excess of toxicity). ATRESS can be a reason for the absence of the OS benefit despite the reduction in DM.

2 September 2022 in Acta Oncologica
Verified
Journal Article
Closed access
AHAnna Hołdakowska
Anna Hołdakowska
JGJean-Pierre Gerard
Jean-Pierre Gerard
Krzysztof BujkoKrzysztof Bujko
Krzysztof Bujko
The impact of the tumour volume or size on achieving clinical complete response (cCR) after radio(chemo)therapy is poorly understood.A literature search was performed to gather data on the predicti...

2 September 2022 in Acta Oncologica
Verified
Journal Article
Closed access
LPLucyna Pietrzak
Lucyna Pietrzak
ACAnna Cencelewicz
Anna Cencelewicz
ARAndrzej Rutkowski
Andrzej Rutkowski
AHAnna Hołdakowska
Anna Hołdakowska
KPKarol Paciorek
Karol Paciorek
FGfor the Polish Colorectal Study Group
for the Polish Colorectal Study Group
The watch-and-wait strategy (w&w) is gaining momentum in rectal cancer [1–8]. Most of the w&w observations come from reports showing the outcomes after neoadjuvant long-course chemoradiation (CRT) ...

17 November 2022 in The Lancet Healthy Longevity
Verified
Journal Article
Open access
JSJoanna Socha
Joanna Socha
Krzysztof BujkoKrzysztof Bujko
Krzysztof Bujko